Fracture healing augmentation with teriparatide therapy: A case study of fracture distal end femur from India

Distal femoral fractures account for about 6-7% of all femoral fracture and often are unstable and comminuted. They have a potential for long term disability. Impaired healing of such fractures further delays the rehabilitation process, thus impacting quality of life. Teriparatide is not an approved drug for treating osteoporosis in India, unlike other countries. Intermittent administration of teriparatide has anabolic effects that stimulate bone formation and activate bone remodeling. The purpose of this case report is to elucidate the Indian experience of 5 cases of use of teriparatide for fracture of distal femur with non-union. In our experience teriparatide therapy was beneficial to bone healing after the fracture of distal end of femur. Further, it may lead to an early return to activity and vocation for patients undergoing fracture distal end femur.